Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Post-Transplant Complications

Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes

Bone Marrow Transplantation volume 27, pages 641–646 (2001)Cite this article

Abstract

The diagnosis and treatment of thrombotic thrombocytopenic purpura (TTP) in patients following BMT are often uncertain and unsuccessful. To better understand the evaluation and management of these patients, we describe 17 patients treated with plasma exchange for a presumptive diagnosis of TTP following BMT during a 10 year period, 1989–1998. Because of the uncertainty of the diagnosis, these patients are described as having a ‘TTP-like syndrome’. All 17 patients had received an allogeneic BMT. Comparison with the other 245 patients who had an allogeneic BMT during the same period demonstrated that patients with a TTP-like syndrome more frequently had unrelated and/or HLA-mismatched donors, and had also experienced more serious complications: grade III–IV acute GVHD and systemic bacterial, fungal, and viral infections. Three months after the diagnosis of the TTP-like syndrome, only four of 17 patients (24%) were alive; currently only one patient survives. These data emphasize: (1) the diagnosis of TTP following BMT is uncertain because of the presence of multiple BMT-associated complications. (2) The outcome of patients with TTP-like syndromes following BMT is poor. (3) Urgent intervention with plasma exchange when TTP is suspected following BMT may not always be appropriate. Alternative explanations for the signs and symptoms should be considered and treated aggressively. Bone Marrow Transplantation (2001) 27, 641–646.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Clark WF, Rock GA, Buskard N et al. Therapeutic plasma exchange: an update from the Canadian Apheresis Group Ann Int Med 1999 131: 453–462

    Article  CAS  PubMed  Google Scholar 

  2. Amorosi EL, Ultmann JE . Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature Medicine 1966 45: 139–159

    Article  Google Scholar 

  3. George JN, El-Harake MA . Thrombocytopenia due to enhanced platelet destruction by nonimmunologic mechanisms. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds).Williams Hematology McGraw-Hill: New York 1995; pp 1290–1314

  4. Rock GA, Shumak KH, Buskard NA et al. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura New Engl J Med 1991 325: 393–397

    Article  CAS  PubMed  Google Scholar 

  5. Thompson CE, Damon LE, Ries CA, Linker CA . Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic Blood 1992 80: 1890–1895

    CAS  PubMed  Google Scholar 

  6. George JN . How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Blood 2000 96: 1223–1229

    CAS  PubMed  Google Scholar 

  7. Pettitt AR, Clark RE . Thrombotic microangiopathy following bone marrow transplantation Bone Marrow Transplant 1994 14: 495–504

    CAS  PubMed  Google Scholar 

  8. Zeigler ZR, Shadduck RK, Nemunaitis J et al. Bone marrow transplant-associated thrombotic microangiopathy: a case series Bone Marrow Transplant 1995 15: 247–253

    CAS  PubMed  Google Scholar 

  9. Schriber JR, Herzig GP . Transplantation-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Semin Hematol 1997 34: 126–133

    CAS  PubMed  Google Scholar 

  10. Iacopino P, Pucci G, Arcese W et al. Gruppo Italiano Trapianto Midollo Osseo (GITMO). Severe thrombotic microangiopathy: an infrequent complication of bone marrow transplantation Bone Marrow Transplant 1999 24: 47–51

    Article  CAS  PubMed  Google Scholar 

  11. Kanamori H, Maruta A, Sasaki S et al. Diagnostic value of hemostatic parameters in bone marrow transplantation-associated thrombotic microangiopathy Bone Marrow Transplant 1998 21: 705–709

    Article  CAS  PubMed  Google Scholar 

  12. Bell WR, Braine HG, Ness PM, Kickler TS . Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome New Engl J Med 1991 325: 398–403

    Article  CAS  PubMed  Google Scholar 

  13. Laszik Z, Silva F . Hemolytic-uremic syndrome, thrombotic thrombocytopenia purpura, and systemic sclerosis (systemic scleroderma). In: Jennett JC, Olson JL, Schwartz MM, Silva FG (eds) Heptinstall's Pathology of the Kidney Lippincott-Raven: Philadelphia 1998 pp 1003–1057

    Google Scholar 

  14. Matsuda Y, Hara J, Miyoshi H et al. Thrombotic microangiopathy associated with reactivation of human herpesvirus-6 following high-dose chemotherapy with autologous marrow transplantation in young children Bone Marrow Transplant 1999 24: 919–923

    Article  CAS  PubMed  Google Scholar 

  15. Mitra D, Jaffe EA, Weksler B et al. Thrombotic thrombocytopenic purpura and sporadic hemolyticuremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells Blood 1997 89: 1224–1234

    CAS  PubMed  Google Scholar 

  16. Dang CT, Magid MS, Weksler B et al. Enhanced endothelial cell apoptosis in splenic tissues of patients with thrombotic thrombocytopenic purpura Blood 1999 93: 1264–1270

    CAS  PubMed  Google Scholar 

  17. Furlan M, Robles R, Galbusera M et al. Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome New Engl J Med 1998 339: 1578–1584

    Article  CAS  PubMed  Google Scholar 

  18. Tsai H-M, Lian ECY . Antibodies to von-Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura New Engl J Med 1998 339: 1585–1594

    Article  CAS  PubMed  Google Scholar 

  19. van der Plas RM, Schiphorst ME, Huizinga EG et al. von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura Blood 1999 93: 3798–3802

    CAS  PubMed  Google Scholar 

  20. Oleksowicz L, Bhagwati N, DeLeon-Fernandez M . Deficient activity of vonWillebrand's factor-cleaving protease in patients with disseminated malignancies Cancer Res 1999 59: 2244–2250

    CAS  PubMed  Google Scholar 

  21. Nürnberger W, Michelmann I, Burdach S, Göbel U . Endothelial dysfunction after bone marrow transplantation: increase of soluble thrombomodulin and PAI-1 in patients with multiple transplant-related complications Ann Hematol 1998 76: 61–65

    Article  PubMed  Google Scholar 

  22. Paquette RL, Tran L, Landaw EM . Thrombotic microangiopathy following allogenic bone marrow transplantation is associated with intensive graft-versus-host disease prophylaxis Bone Marrow Transplant 1998 22: 351–357

    Article  CAS  PubMed  Google Scholar 

  23. Rizvi MA, Vesely SK, George JN et al. Plasma exchange complications in 71 consecutive patients treated for clinically suspected thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Transfusion 2000 40: 896–901

    Article  CAS  PubMed  Google Scholar 

  24. Sarode R, McFarland JG, Flomenberg N et al. Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation Bone Marrow Transplant 1995 16: 271–275

    CAS  PubMed  Google Scholar 

  25. Milone J, Napal J, Bordone J et al. Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses BoneMarrow Transplant 1998 22: 1019–1021

    CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by the Hemostasis Research Fund of the University of Oklahoma Health Sciences Center. We thank Dr Georgia Vogelsang for continuing critical advice.

Author information

Authors and Affiliations

  1. Department of Medicine, Hematology-Oncology Section, The University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA

    V Roy, MA Rizvi, SK Vesely & JN George

Authors
  1. V Roy
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. MA Rizvi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. SK Vesely
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. JN George
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Roy, V., Rizvi, M., Vesely, S. et al. Thrombotic thrombocytopenic purpura-like syndromes following bone marrow transplantation: an analysis of associated conditions and clinical outcomes. Bone Marrow Transplant 27, 641–646 (2001). https://doi.org/10.1038/sj.bmt.1702849

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1702849

Keywords

This article is cited by

Search

Advanced search

Quick links